Case Report

Case Report of a Child with Beta Thalassemia Major in a Tribal Region of India

Neha Chauhan, Prakash Narayan, Mahesh Narayan and Manisha Shukla*

Published: 08 September, 2023 | Volume 7 - Issue 1 | Pages: 005-007

Introduction: Thalassemia is an inherited blood disorder of haemoglobin (Hb) synthesis, which affects different regions around the world. India has the largest number of children with beta-thalassemia major in the world, particularly in the tribal population. Heterozygous conditions are milder and even go unreported than the condition of homozygous where regular blood transfusion is required.
Case report: This report focuses on a case of major beta-thalassemia in a child, whose parents are beta thalassemia minor to intermediate conditions, and who was treated by blood transfusion once a month. However, Thalassemia may be cured by allogeneic hematopoietic stem cell transplantation, although not everyone is a good candidate. Genetic counselling, prenatal diagnosis, and selective termination of affected fetuses are effective ways to control thalassemia.
Discussion and conclusion: The paper reports a unique case of Thalassemia in rural India. The blood disorder while commonly presented in a juvenile whose parents were Thalassemia positive resulted in the termination of a fetus diagnosed with it. It archives the story of the parents who are now in the process of planning future offspring while mitigating disease risk. The case leads the way for effective management and containment of hereditary genetic disorders through carrier detection while planning alliances and offspring.

Read Full Article HTML DOI: 10.29328/journal.jcavi.1001011 Cite this Article Read Full Article PDF


Beta-thalassemia; Blood transfusion; Genetic disorder; Hemoglobin


  1. Thein SL. The molecular basis of β-thalassemia. Cold Spring Harb Perspect Med. 2013 May 1;3(5):a011700. doi: 10.1101/cshperspect.a011700. PMID: 23637309; PMCID: PMC3633182.
  2. Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010 Feb;12(2):61-76. doi: 10.1097/GIM.0b013e3181cd68ed. PMID: 20098328.
  3. Banjade P, Bhandari J. A Child Lost to Follow Up Carrying Beta Thalassemia Major: A Case Report. JNMA J Nepal Med Assoc. 2020 Jun 30;58(226):436-438. doi: 10.31729/jnma.5129. PMID: 32788765; PMCID: PMC7580351.
  4. De Simone G, Quattrocchi A, Mancini B, di Masi A, Nervi C, Ascenzi P. Thalassemias: from gene to therapy. Mol Aspects Med. 2022 Apr;84:101028. doi: 10.1016/j.mam.2021.101028. Epub 2021 Oct 11. PMID: 34649720.
  5. Banjade P, Bhandari J. A Child Lost to Follow Up Carrying Beta Thalassemia Major: A Case Report. JNMA J Nepal Med Assoc. 2020 Jun 30;58(226):436-438. doi: 10.31729/jnma.5129. PMID: 32788765; PMCID: PMC7580351.
  6. National Health Mission - Guidelines on Hemoglobinopathies in India: Prevention and control of hemoglobinopathies in India. 1-138, 2016. http://nhm.gov.in/images/pdf/programmes/RBSK/Resource_Documents/Guidelines_on_Hemoglobinopathies_in India.pdf.
  7. Chourasia S, Kumar R, Singh MPSS, Vishwakarma C, Gupta AK, Shanmugam R. High Prevalence of Anemia and Inherited Hemoglobin Disorders in Tribal Populations of Madhya Pradesh State, India. Hemoglobin. 2020 Nov;44(6):391-396. doi: 10.1080/03630269.2020.1848859. Epub 2020 Nov 22. PMID: 33222570.
  8. Yadav SS, Panchal P, Menon KC. Prevalence and Management of β-Thalassemia in India. Hemoglobin. 2022 Jan;46(1):27-32. doi: 10.1080/03630269.2021.2001346. Epub 2022 Feb 7. PMID: 35129043.
  9. Gomber S, Jain P, Sharma S, Narang M. Comparative Efficacy and Safety of Oral Iron Chelators and their Novel Combination in Children with Thalassemia. Indian Pediatr. 2016 Mar;53(3):207-10. doi: 10.1007/s13312-016-0821-4. PMID: 27029681.
  10. Lucarelli G, Isgrò A, Sodani P, Gaziev J. Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia. Cold Spring Harb Perspect Med. 2012 May;2(5):a011825. doi: 10.1101/cshperspect.a011825. PMID: 22553502; PMCID: PMC3331690.
  11. Ghosh K, Colah R, Manglani M, Choudhry VP, Verma I, Madan N, Saxena R, Jain D, Marwaha N, Das R, Mohanty D, Choudhary R, Agarwal S, Ghosh M, Ross C. Guidelines for screening, diagnosis and management of hemoglobinopathies. Indian J Hum Genet. 2014 Apr;20(2):101-19. doi: 10.4103/0971-6866.142841. PMID: 25400338; PMCID: PMC4228561.
  12. Peters M, Heijboer H, Smiers F, Giordano PC. Diagnosis and management of thalassaemia. BMJ. 2012 Jan 25;344:e228. doi: 10.1136/bmj.e228. PMID: 22277544.
  13. Shander A, Cappellini MD, Goodnough LT. Iron overload and toxicity: the hidden risk of multiple blood transfusions. Vox Sang. 2009 Oct;97(3):185-97. doi: 10.1111/j.1423-0410.2009.01207.x. Epub 2009 Aug 3. PMID: 19663936.
  14. Neufeld EJ. Update on iron chelators in thalassemia. Hematology Am Soc Hematol Educ Program. 2010;2010:451-5. doi: 10.1182/asheducation-2010.1.451. PMID: 21239834.
  15. Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012 Oct;10(4):411-22. doi: 10.2450/2012.0008-12. Epub 2012 Jun 27. PMID: 22790257; PMCID: PMC3496216.


Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?